ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $1,957,000 | -63.5% | 123,900 | -73.5% | 0.00% | -83.3% |
| Q2 2017 | $5,356,000 | -67.2% | 467,813 | -40.3% | 0.02% | -67.3% |
| Q1 2017 | $16,305,000 | -2.6% | 783,889 | -2.6% | 0.06% | -6.8% |
| Q4 2016 | $16,742,000 | -45.4% | 804,885 | -14.0% | 0.06% | -46.4% |
| Q3 2016 | $30,654,000 | +48.8% | 935,441 | +13.4% | 0.11% | +46.7% |
| Q2 2016 | $20,600,000 | +99.0% | 824,988 | +95.2% | 0.08% | +97.4% |
| Q1 2016 | $10,352,000 | -45.7% | 422,718 | -26.7% | 0.04% | -46.5% |
| Q4 2015 | $19,059,000 | -40.8% | 577,014 | -41.2% | 0.07% | -46.2% |
| Q3 2015 | $32,174,000 | -35.0% | 982,107 | +5.1% | 0.13% | -27.1% |
| Q2 2015 | $49,515,000 | – | 934,777 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 1,628,328 | $33,869,000 | 14.72% |
| Foresite Capital Management II, LLC | 995,396 | $20,704,000 | 10.39% |
| Cormorant Asset Management, LP | 1,581,604 | $32,897,000 | 4.43% |
| DAFNA Capital Management LLC | 221,013 | $4,597,000 | 4.04% |
| New Leaf Venture Partners, L.L.C. | 228,428 | $4,751,000 | 3.40% |
| Partner Investment Management, L.P. | 63,571 | $1,322,000 | 1.75% |
| Iguana Healthcare Management, LLC | 140,000 | $2,912,000 | 1.74% |
| PFM Health Sciences, LP | 2,913,951 | $60,610,000 | 1.71% |
| Redmile Group, LLC | 920,550 | $19,147,000 | 1.65% |
| SECTORAL ASSET MANAGEMENT INC | 669,351 | $13,923,000 | 1.54% |